Multiple digestive diseases, including IBD, AP, and nonalcoholic steatohepatitis (NASH), reportedly elevate ER stress and ROS levels, possibly contributing to elevated PAD4 activation and NETs levels (49–51). This evidence concerns the gene PADI4 and metabolic dysfunction-associated steatohepatitis.